ACDL

Applied DNA Launches Mpox Clade I and Clade II Testing Service

STONY BROOK, N.Y. September 11, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has launched an expansion of its clinical testing services for the detection of Mpox (formerly monkeypox) to include testing for both mpox [...]

2024-09-18T15:56:46-04:00Categories: ACDL, mpox, Press Release|

Applied DNA Submits Validation Package to New York State Department of Health toExpand Linea Mpox Virus 1.0 Assay to Mpox Clade I

STONY BROOK, NY. August 23, 2024 - Applied DNA Sciences, Inc. (NASDAQ:APDN) (the”Company”), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has submitted a validation package to the New York State Department of [...]

2024-09-19T11:24:19-04:00Categories: ACDL, mpox, Press Release|

APDN Partners with GenXys to Deploy Clinical Decision Support System for PGx Testing

STONY BROOK, N.Y., June 18, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics subsidiary, Applied DNA Clinical Labs, LLC (ADCL), will utilize the GenXys Health Care Systems (GenXys) suite of clinical decision support software for interpretation and reporting [...]

2024-06-18T07:07:32-04:00Categories: ACDL, Press Release|

APDN Submits Validation Package to NYS DOH for Approval of PGx Assay

STONY BROOK, N.Y. – March 22, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has submitted a validation package to the New York State Department of Health (NYSDOH) in support of [...]

2023-03-22T10:49:43-04:00Categories: ACDL, Press Release|Tags: , |

Job Posting: Specimen Accessioner

The Specimen Accessioner works closely with Applied DNA Clinical Labs personnel to catalog patient specimens, such as: swab, transport media, body fluids (blood, urine, etc.) or tissue samples, for review. Those samples are processed and examined by laboratory professionals, doctors, and nurses for diagnosis and treatment. Job Duties and Responsibilities Verifies all specimens that [...]

2022-01-05T12:42:02-05:00Categories: ACDL, Corporate/Financial News|Tags: , |

Job Posting: Diagnostic Sales Representative

The Diagnostic Sales Account Representative will be responsible for selling the portfolio of existing products into established and developing markets. They will accomplish this by calling on Public Health Departments, State Department of Health Labs, Reference Laboratories, Hospitals, Infectious Disease Physicians, Physicians, Specialists, Pathologists, and all associated stakeholders. Essential Duties and Responsibilities: [...]

COVID-19 Surveillance Testing at SBUH

Program to Support Weekly Testing of Up to 9,000 Faculty and Staff at Peak Operations, Equates to Use of Approximately 1,800 Tests per Week; Applied DNA Receives Initial Stocking Order Under Master Services Agreement STONY BROOK, N.Y. – November 10, 2020 - Applied DNA Sciences, Inc., (NASDAQ: APDN) (“Applied [...]

The Value of Sensitive Pooled Surveillance Testing

Small businesses and community groups have been particularly hard hit by COVID-19, both financially and in the availability and continuity of their essential staff. We have been conducting daily COVID-19 pooled surveillance testing for one such cohort of approximately 25 individuals of a 3-generational family plus friends, neighbors and household [...]

2022-01-20T12:11:25-05:00Categories: ACDL, blog, Coronavirus, Surveillance Testing|Tags: |
Go to Top